Safety and Immunogenicity of the Butantan Quadrivalent Influenza Vaccine
Clinical trial NCT03927131 · COMPLETED
Trial details
- NCT number
- NCT03927131
- Sponsor
- Butantan Institute
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-12
- Primary completion
- 2023-10-13
- Enrollment
- 5822
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.